Keyphrases
Metabolic Profiling
100%
Primary Sclerosing Cholangitis
100%
Bile
100%
Metabolic Signature
100%
Portal Blood
100%
Metabolomics
25%
Enterohepatic Circulation
25%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
16%
Portal Venous Blood
16%
Metabolic
8%
Etiology
8%
Patient Matched
8%
Complex Lipids
8%
Disease Control
8%
Liver Disease
8%
Liver Transplantation
8%
Pharmacologic
8%
Disease Groups
8%
Viral
8%
Dipeptide
8%
Evidence Support
8%
Pharmacotherapy
8%
Living Donor
8%
Between-group
8%
In Vivo Evidence
8%
Pathophysiologic Mechanisms
8%
Mass Spectroscopy
8%
Biological Fluids
8%
End-stage Liver Disease
8%
Lipidomic Profiling
8%
Gene Set Enrichment Analysis
8%
Bile Duct
8%
Bile Formation
8%
Hypothesis Testing
8%
Fibroinflammatory Disease
8%
Lipidome
8%
Principal Coordinate Analysis (PCoA)
8%
Non-hepatic
8%
Global Metabolomics Profiling
8%
Differential Mobility
8%
DMSMS
8%
Polyamine Metabolites
8%
U-test
8%
Global Lipidomics
8%
Chemical Footprint
8%
Biochemistry, Genetics and Molecular Biology
Metabolomics
100%
Metabolite
100%
Metabolome
60%
Enterohepatic Circulation
60%
Lipid
20%
Lipidomics
20%
Liquid Chromatography-Mass Spectrometry
20%
Tandem Mass Spectrometry
20%
Lipidome
20%
Hepatitis Virus
20%
Principal Component Analysis
20%
Dipeptide
20%
Drug Therapy
20%
Immunology and Microbiology
Primary Sclerosing Cholangitis
100%
Metabolite
41%
Metabolome
25%
Enterohepatic Circulation
25%
Venous Blood
16%
Liver Transplantation
8%
Tandem Mass Spectrometry
8%
Bile Duct
8%
Hepatitis Virus
8%
Liquid Chromatography Tandem Mass Spectrometry
8%
Drug Therapy
8%
Dipeptide
8%